Shotlee LogoShotlee
Blog
Download on theApp Store
Get it onGoogle Play
Skip to main content
Could This Be the 'Ozempic of Alcohol'? Existing Medication Shows Promise - Featured image
Health

Could This Be the 'Ozempic of Alcohol'? Existing Medication Shows Promise

Dr. Adrian Vale, MD
Reviewed by Dr. Adrian Vale, MDInternal Medicine · Board-Certified Obesity Medicine
·December 8, 2025·3 min read

Track Smart

Calculate active GLP-1 levels automatically with Shotlee.

Download →

An affordable and readily accessible medication is gaining attention as a potential solution for curbing alcohol cravings, drawing comparisons to the way GLP-1 drugs manage food cravings. Naltrexone, by impacting dopamine-reward pathways, reduces the satisfying feeling associated with alcohol consumption, thus diminishing the desire for it. Research and anecdotal evidence suggest it could be a game-changer for many.

Share

Could This Be the 'Ozempic of Alcohol'? Existing Medication Shows Promise

A readily available and inexpensive pill is being touted as the "Ozempic of alcohol" because of its potential to decrease cravings for alcohol, similar to how GLP-1 medications reduce food cravings.

Naltrexone, costing approximately $1.60 per pill when purchased in bulk, functions by obstructing opioid receptors in the brain, thereby lessening the dopamine-reward effect individuals experience from drinking, which in turn reduces the urge for alcohol.

In essence, alcohol ceases to provide the same level of satisfaction, which aids in reducing the desire for it.

Since 1994, the US Food and Drug Administration has given its approval to Naltrexone for the treatment of alcohol use disorder, and since 1984 for opiate dependence.

Nearly 28 million individuals in the United States grapple with alcohol use disorder.

The Centers for Disease Control and Prevention estimates that 17% of adult Americans engage in binge drinking, a pattern more prevalent among men. Heavy drinking can take a toll on finances, health and lead to tragic outcomes. Health tracking apps like Shotlee can help monitor alcohol consumption and related health data.

Research indicates that among users who took naltrexone, a prescription medication, an hour prior to drinking, 80% experienced a significant reduction or complete elimination of their alcohol consumption.

Besides the pill form, Oar Health markets naltrexone as a mint under the name Clutch. For individuals who struggle with adherence, the drug is also available as a once-a-month injection.

Nausea and headaches have been reported as side effects of naltrexone, but specialists note that the nausea tends to diminish as patients become accustomed to the treatment.

This characteristic differentiates naltrexone from acamprosate, another approved medication for alcohol use disorder, which necessitates monitoring by a healthcare professional due to potential side effects like suicidal thoughts and depression.

Precision tracking for your journey

Join thousands using Shotlee to accurately track GLP-1 medications and side effects.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store
Get it onGoogle Play

Furthermore, unlike disulfiram, another drug approved for treating alcohol use disorder that induces unpleasant and potentially life-threatening side effects when combined with alcohol, naltrexone does not mandate strict abstinence from alcohol.

For many individuals, naltrexone has proven to be a transformative solution.

Military veteran and podcast host Jesse Carrajat stated, "The first time I took naltrexone, I remember not just wanting to impulsively turn to alcohol. It was gone... For the first time in my life, when things got hard, I wasn't turning to alcohol."

His personal experience is echoed in the comments shared on his TikTok account.

One user commented, "I had tried so many times to detox on my own, and it did not work. Naltrexone saved me."

Another user stated, "Worked instantly for me 4 months alcohol free."

Meanwhile, a Reddit user who had struggled with alcohol since his teenage years and gradually saw his dependence affect his quality of life said that his first dose of naltrexone resulted in an immediate reframe of his drinking habits.

He explained, "The first time I took it, I still drank, arguably quite a lot, but I didn't spiral. I didn't lose control... I left the party at a decent time, 1 AM, because I was tired. I woke up the next morning feeling surprisingly fresh... That alone felt like a miracle."

The subsequent year, the man exclusively used naltrexone before significant occasions and high-risk situations, but by 2025, he committed to taking the pill each time he consumed alcohol.

He declared, "Now? I barely think about drinking... The Friday craving is gone... I can have a beer at a bar with friends and stop after one or two. And if I don't drink, I don't feel deprived, I just feel normal."

Source Information

Originally published by New York Post.Read the original article →

Read next

Keep exploring

More on Ozempic

Articles covering Ozempic dosing, side effects, and clinical updates.

Ozempic and Male Fertility: Can Semaglutide Boost Sperm Quality?
Health & Wellness

Ozempic and Male Fertility: Can Semaglutide Boost Sperm Quality?

Emerging research indicates that GLP-1 medications, including Ozempic and Mounjaro, may offer unexpected benefits for male reproductive health by addressing underlying metabolic issues.

7 min read
Semaglutide and Male Fertility: New Study Reveals Testosterone Boost
Health & Wellness

Semaglutide and Male Fertility: New Study Reveals Testosterone Boost

Can GLP-1 medications like Ozempic or Wegovy improve male fertility? A new study indicates potential benefits for testosterone and sperm health, but what does this mean for patients?

7 min read
Semaglutide and Blood Pressure Meds: Why Dizziness Risk Is Rising
Health & Wellness

Semaglutide and Blood Pressure Meds: Why Dizziness Risk Is Rising

A new study reveals a potential safety concern when combining GLP-1 medications with blood pressure drugs, highlighting the importance of monitoring hypotensive episodes in select patients.

8 min read

Same topic: Addiction

All Addiction articles →
Dopamine Addiction, GLP-1 Medications & Pollution | A Third Opinion Podcast
Health

Dopamine Addiction, GLP-1 Medications & Pollution | A Third Opinion Podcast

This article examines differing viewpoints on contemporary health issues. It delves into pollution in Delhi, the increasing popularity of GLP-1 drugs, and the potential for dopamine addiction in today's society.

1 min read
Brain Scientists Aim to Develop Weight-Loss Medications Without Nausea
Health

Brain Scientists Aim to Develop Weight-Loss Medications Without Nausea

Scientists are striving to develop weight-loss drugs that don't cause nausea, a common side effect of medications like Wegovy and Zepbound. Research is focused on targeting specific brain regions to suppress appetite effectively without triggering nausea or other adverse effects.

4 min read

More in Health

Wegovy, Zepbound & More: Hers Makes GLP-1s Accessible from $39
Health & Wellness

Wegovy, Zepbound & More: Hers Makes GLP-1s Accessible from $39

The journey to weight loss can be challenging, and for many, advanced medications like GLP-1 injectables offer a crucial pathway. However, their high cost often presents a significant barrier. Hers is changing this landscape by making popular GLP-1 and other weight loss treatments more accessible and affordable than ever before.

7 min read
Ozempic and the Shift: Real Data on America's Obesity Rates
Health & Wellness

Ozempic and the Shift: Real Data on America's Obesity Rates

New data from EPIC Research highlights a correlation between rising GLP-1 prescriptions and a modest decline in US obesity rates, offering hope amidst ongoing challenges.

7 min read
Share this article
  1. Home
  2. Blog
  3. Could This Be the 'Ozempic of Alcohol'? Existing Medication Shows Promise
Dr. Adrian Vale, MD — Internal Medicine · Board-Certified Obesity Medicine
Medically reviewed

Dr. Adrian Vale, MD

Internal Medicine · Board-Certified Obesity Medicine

Dr. Adrian Vale is a board-certified internal medicine physician with a clinical focus on obesity medicine and metabolic health. He reviews Shotlee guides and articles on GLP-1 medications, peptide therapy, and weight-management protocols for clinical accuracy.

View all articles reviewed by Dr. Adrian Vale, MD
Shotlee LogoShotlee

Your comprehensive health tracking companion. Track, analyze, and optimize your journey with advanced metrics and community support.

Product

  • Medication Trackers
  • Health Guides
  • Calculators
  • Compare Medications
  • Pricing

Resources

  • Health Blog
  • Support Center

Legal

  • Privacy Policy
  • Terms of Service
  • Community Guidelines
  • Refund Policy

© 2026 Shotlee. All rights reserved.

Made with for the community♥ for the community